Mr. Osborne et al., IDENTIFICATION OF THE MAJOR TAMOXIFEN-DEOXYGUANOSINE ADDUCT FORMED INTHE LIVER DNA OF RATS TREATED WITH TAMOXIFEN, Cancer research, 56(1), 1996, pp. 66-71
The antiestrogenic drug tamoxifen induces liver tumors in rats by a ge
notoxic mechanism. The key step has been proposed to be the formation
of a reactive carbocation from the metabolite alpha-hydroxytamoxifen.
This compound reacts with DNA in vitro to a small extent (1 in 10(5) D
NA bases), giving products identical to those found in rat liver cells
treated with tamoxifen. Now we have prepared the more reactive alpha-
acetoxytamoxifen, which reacts with DNA in vitro to a much greater ext
ent (1 in 50 bases). The products of this reaction were subjected to P
-32 postlabeling and shown by both TLC and reverse-phase liquid chroma
tography to be identical to those isolated from DNA treated with alpha
-hydroxytamoxifen and to those found in the liver DNA of rat hepatocyt
es treated with tamoxifen or of the livers of rats treated with tamoxi
fen. The major product was also isolated as the nucleoside and charact
erized by UV, mass, and proton magnetic resonance spectroscopy. It is
an adduct of tamoxifen and deoxyguanosine in which the alpha position
of tamoxifen is linked covalently to the exocyclic amino group of deox
yguanosine.